leisure time -WSS

leisure time

author：explore 2025-09-14 18:32:33 - browse：2682

Illustration of miniature doctor figurines standing on a stethoscope with a roll of money to the right. — Adobe

Physician staffing firms, flailing in the wake of a federal law banning surprise bills, are demanding extra payment from hospitals to stay afloat. Hospitals, desperate for doctors to staff their facilities, have little choice but to comply.

It’s a big topic of conversation on for-profit hospital earnings calls. Just last week, major hospital chains said those expenses, known as physician subsidies, were up 20% to 40% from last year. And experts say it’s just as bad at not-for-profit hospitals. It’s a complicated problem that’s gotten worse just as contract labor expenses — hospitals’ hallmark problem of the past three years — ease up.

“This is the new contract labor,” said Whit Mayo, senior managing director with Leerink Partners. “This is the new cost issue that the industry is having to deal with.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Having children helps parents live longer, especially after age 80

WSS

Carvykti CAR

Prime Medicine, Myeloid Therapeutics clash over genome

Here’s what’s in the FDA plan to include pregnant women in clinical trials

David Ricks of Eli Lilly: best biopharma CEO of 2023

Why don't Americans have at

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Wikipedia

leisure time

entertainment

At least 13 dead in Texas as scorching temps continue

SNAP should offer more nutrition education

At least 13 dead in Texas as scorching temps continue

CRISPR gene editing developments we’re watching in 2024

Novavax promises a turnaround & Lilly roils the obesity market

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Hospitals owned by private equity see complications spike 25%

Drug repurposing or repositioning? The language matters

Abbott's new heart device gets FDA advisory panel nod

focus

Christmas in the PICU brings some surprising joy

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Resistance to opioid

AMAs digital advisors table RPM coding reform proposal, again

Why don't Americans have at

Three trends to watch in biotech in 2024

explore

focus

leisure time

hotspot